Dr. David Neidhardt, MD

NPI: 1396797510
Total Payments
$254,409
2024 Payments
$34,023
Companies
39
Transactions
647
Medicare Patients
6,143
Medicare Billing
$440,337

Payment Breakdown by Category

Consulting$247,388 (97.2%)
Food & Beverage$5,844 (2.3%)
Travel$1,158 (0.5%)
Education$19.90 (0.0%)
Other$0.00 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $247,388 155 97.2%
Food and Beverage $5,844 479 2.3%
Travel and Lodging $1,158 11 0.5%
Education $19.90 2 0.0%

Top Paying Companies

Company Total Records Latest Year
Takeda Pharmaceuticals U.S.A., Inc. $173,598 130 $0 (2024)
Shire North American Group Inc $75,056 44 $0 (2019)
Novo Nordisk Inc $920.70 135 $0 (2023)
ABBVIE INC. $833.75 65 $0 (2024)
Boehringer Ingelheim Pharmaceuticals, Inc. $523.60 31 $0 (2024)
AstraZeneca Pharmaceuticals LP $430.02 31 $0 (2024)
Lilly USA, LLC $344.86 25 $0 (2024)
PFIZER INC. $327.29 28 $0 (2024)
Amgen Inc. $308.26 21 $0 (2024)
SANOFI-AVENTIS U.S. LLC $235.89 18 $0 (2023)

Payment History by Year

Year Amount Transactions Top Company
2024 $34,023 69 Takeda Pharmaceuticals U.S.A., Inc. ($33,267)
2023 $30,089 81 Takeda Pharmaceuticals U.S.A., Inc. ($29,217)
2022 $42,453 94 Takeda Pharmaceuticals U.S.A., Inc. ($41,622)
2021 $45,158 92 Takeda Pharmaceuticals U.S.A., Inc. ($44,445)
2020 $25,601 68 Takeda Pharmaceuticals U.S.A., Inc. ($25,009)
2019 $32,215 81 Shire North American Group Inc ($31,656)
2018 $21,601 78 Shire North American Group Inc ($20,900)
2017 $23,270 84 Shire North American Group Inc ($22,500)

All Payment Transactions

647 individual payment records from CMS Open Payments — Page 1 of 26

Date Company Product Nature Form Amount Type
12/27/2024 Mylan Specialty L.P. YUPELRI (Drug) Food and Beverage In-kind items and services $28.49 General
Category: Anticholinergics, Inhaled
12/23/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $14.66 General
Category: Gastroenterology
12/16/2024 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $1,100.00 General
12/04/2024 PFIZER INC. ELIQUIS (Drug), NURTEC ODT Food and Beverage In-kind items and services $13.15 General
Category: CARDIOVASCULAR;METABOLIC DISEASE
11/21/2024 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug) Food and Beverage In-kind items and services $15.41 General
Category: RESPIRATORY
11/19/2024 Sumitomo Pharma America, Inc. GEMTESA (Drug) Food and Beverage In-kind items and services $15.45 General
Category: UROLOGY
11/13/2024 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $2,200.00 General
11/12/2024 Lilly USA, LLC MOUNJARO (Drug) Food and Beverage In-kind items and services $15.89 General
Category: Diabetes
11/05/2024 Radius Health, Inc. Tymlos (Drug) Food and Beverage In-kind items and services $15.30 General
Category: Endocrinology
11/01/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $12.92 General
Category: NEUROSCIENCE
10/29/2024 AstraZeneca Pharmaceuticals LP AIRSUPRA (Drug) Food and Beverage In-kind items and services $14.05 General
Category: Respiratory
10/25/2024 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug) Food and Beverage In-kind items and services $13.20 General
Category: RESPIRATORY
10/22/2024 Amgen Inc. EVENITY (Biological), Prolia Food and Beverage In-kind items and services $17.42 General
Category: Bone Health
10/09/2024 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $2,200.00 General
10/02/2024 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $550.00 General
09/27/2024 PFIZER INC. PREVNAR 20 (Biological), COMIRNATY, ABRYSVO Food and Beverage In-kind items and services $18.71 General
Category: VACCINES
09/24/2024 AstraZeneca Pharmaceuticals LP AIRSUPRA (Drug) Food and Beverage In-kind items and services $14.05 General
Category: Respiratory
09/20/2024 ABBVIE INC. LINZESS (Drug), CREON Food and Beverage In-kind items and services $21.35 General
Category: GASTROENTEROLOGY
09/17/2024 Boehringer Ingelheim Pharmaceuticals, Inc. JARDIANCE (Drug) Food and Beverage In-kind items and services $13.94 General
Category: DIABETES
09/13/2024 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $1,100.00 General
09/11/2024 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $2,200.00 General
09/10/2024 Lilly USA, LLC MOUNJARO (Drug) Food and Beverage In-kind items and services $14.67 General
Category: Diabetes
08/27/2024 AstraZeneca Pharmaceuticals LP AIRSUPRA (Drug) Food and Beverage In-kind items and services $14.57 General
Category: Respiratory
08/23/2024 AIMMUNE THERAPEUTICS, INC. ZENPEP (Drug) Food and Beverage In-kind items and services $16.38 General
Category: ENDOCRINE PANCREATIC INSUFFICIENCY
08/13/2024 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $23.59 General
Category: Cardiovascular and Metabolism

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 17 1,474 2,702 $217,347 $100,728
2022 21 1,532 2,477 $205,271 $86,328
2021 22 1,536 2,751 $217,532 $128,779
2020 22 1,601 2,544 $208,044 $124,502
Total Patients
6,143
Total Services
10,474
Medicare Billing
$440,337
Procedure Codes
82

All Medicare Procedures & Services

82 procedure records from CMS Medicare Utilization — Page 1 of 4

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99231 Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes Facility 2023 200 954 $62,010 $36,595 59.0%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 249 492 $46,740 $13,741 29.4%
99221 Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes Facility 2023 192 204 $24,480 $13,085 53.5%
90677 Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use Office 2023 44 44 $11,855 $11,618 98.0%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2023 190 190 $28,500 $8,197 28.8%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 117 157 $20,410 $6,276 30.7%
G0438 Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit Office 2023 24 24 $4,200 $1,992 47.4%
99495 Transitional care management services for problem of at least moderate complexity Office 2023 26 30 $5,250 $1,845 35.2%
G0008 Administration of influenza virus vaccine Office 2023 64 64 $1,600 $1,568 98.0%
83036 Hemoglobin a1c level Office 2023 81 152 $4,560 $1,428 31.3%
90688 Influenza vaccine, quadrivalent, 0.5 ml dosage Office 2023 64 64 $1,920 $1,309 68.2%
G0009 Administration of pneumococcal vaccine Office 2023 44 44 $1,100 $1,078 98.0%
69210 Removal of impacted ear wax Office 2023 27 35 $2,100 $1,012 48.2%
82962 Blood glucose (sugar) test performed by hand-held instrument Office 2023 83 164 $1,312 $520.02 39.6%
81000 Manual urinalysis test with examination using microscope, non-automated Office 2023 30 45 $360.00 $177.30 49.3%
82044 Urine microalbumin (protein) analysis Office 2023 25 25 $250.00 $152.75 61.1%
93000 Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report Office 2023 14 14 $700.00 $132.90 19.0%
99231 Follow-up hospital inpatient care per day, typically 15 minutes Facility 2022 198 769 $49,985 $22,973 46.0%
99221 Initial hospital inpatient care per day, typically 30 minutes Facility 2022 179 189 $22,680 $14,771 65.1%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 245 427 $40,565 $11,909 29.4%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 170 214 $27,820 $8,756 31.5%
90677 Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use Office 2022 30 30 $7,550 $7,189 95.2%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2022 161 161 $24,175 $6,788 28.1%
G0438 Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit Office 2022 47 47 $8,225 $2,573 31.3%
G0008 Administration of influenza virus vaccine Office 2022 76 76 $1,895 $1,833 96.7%

About Dr. David Neidhardt, MD

Dr. David Neidhardt, MD is a Family Medicine healthcare provider based in Lima, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/16/2006. The National Provider Identifier (NPI) number assigned to this provider is 1396797510.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Neidhardt, MD has received a total of $254,409 in payments from pharmaceutical and medical device companies, with $34,023 received in 2024. These payments were reported across 647 transactions from 39 companies. The most common payment nature is "Consulting Fee" ($247,388).

As a Medicare-enrolled provider, Neidhardt has provided services to 6,143 Medicare beneficiaries, totaling 10,474 services with total Medicare billing of $440,337. Data is available for 4 years (2020–2023), covering 82 distinct procedure/service records.

Practice Information

  • Specialty Family Medicine
  • Location Lima, OH
  • Active Since 05/16/2006
  • Last Updated 06/04/2008
  • Taxonomy Code 207Q00000X
  • Entity Type Individual
  • NPI Number 1396797510

Products in Payments

  • Ozempic (Drug) $533.70
  • JARDIANCE (Drug) $369.36
  • FARXIGA (Drug) $337.79
  • VRAYLAR (Drug) $244.21
  • LINZESS (Drug) $235.65
  • UBRELVY (Drug) $206.60
  • XIFAXAN (Drug) $201.37
  • XARELTO (Drug) $192.13
  • ENTRESTO (Drug) $190.08
  • Victoza (Drug) $165.24
  • EVENITY (Biological) $147.01
  • SOLIQUA 100/33 (Biological) $138.77
  • STIOLTO RESPIMAT (Drug) $121.11
  • Livalo (Drug) $117.39
  • MOUNJARO (Drug) $116.93
  • QULIPTA (Drug) $109.11
  • TRULICITY (Drug) $97.39
  • JANUVIA (Drug) $91.99
  • VIBERZI (Drug) $90.33
  • GEMTESA (Drug) $85.24

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Family Medicine Doctors in Lima